Modalis Therapeutics is a company that provides Gene, Medical equipment, Viral vector and more. Modalis Therapeutics is headquartered in Japan Tokyo. Modalis Therapeutics was founded in 2016. and was founded by Haru Morita, Osamu Nureki. Modalis Therapeutics has a total of 94 patents
Biopharmaceutical Venture Capital Trends: Coronavirus Disease
CRISPR Cas9 Market
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Modalis Therapeutics
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Modalis Therapeutics
Sign up to view the full data
Free Trial Now
Download
Top Related Companies
Sign up to view the full data
Free Trial Now
Modalis Therapeutics Frequently Asked Questions
What is Modalis Therapeutics's industry?
Modalis Therapeutics is in the industry of:Research and Development in the Physical, Engineering, and Life SciencesPharmaceutical and Medicine Manufacturing
What technical fields has Modalis Therapeutics researched?
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary...